Wolfe Research upgrades Biogen, AbbVie on pipeline strength and valuation
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
| AbbVie (NYSE: ABBV) | Delayed: 286.39 -0.35 (0.12%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $286.74 | 52 Week High | $68.12 | |||
| Open | $283.88 | 52 Week Low | $50.71 | |||
| Day High | $287.32 | P/E | 62.12 | |||
| Day Low | $283.12 | EPS | $4.61 | |||
| Volume | 3,269,361 | |||||
| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 252.73 +0.47 (0.19%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $252.26 | 52 Week High | $333.65 | |||
| Open | $250.35 | 52 Week Low | $223.02 | |||
| Day High | $253.98 | P/E | 32.36 | |||
| Day Low | $248.46 | EPS | $7.81 | |||
| Volume | 1,393,389 | |||||
